Catalyst Funds Management Pty LTD Chimerix Inc Transaction History
Catalyst Funds Management Pty LTD
- $382 Billion
- Q1 2025
A detailed history of Catalyst Funds Management Pty LTD transactions in Chimerix Inc stock. As of the latest transaction made, Catalyst Funds Management Pty LTD holds 19,436 shares of CMRX stock, worth $165,983. This represents 0.04% of its overall portfolio holdings.
Number of Shares
19,436Holding current value
$165,983% of portfolio
0.04%Shares
1 transactions
Others Institutions Holding CMRX
# of Institutions
133Shares Held
72MCall Options Held
293KPut Options Held
133K-
Beryl Capital Management LLC Redondo Beach, CA3.93MShares$33.5 Million13.93% of portfolio
-
Magnetar Financial LLC Evanston, IL3.92MShares$33.5 Million1.23% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.77MShares$32.2 Million0.81% of portfolio
-
Alliancebernstein L.P. New York, NY3.7MShares$31.6 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.65MShares$31.2 Million0.0% of portfolio
About CHIMERIX INC
- Ticker CMRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,622,896
- Market Cap $748M
- Description
- Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...